Report Description

Global autoinjectors market is anticipated to grow at an impressive growth in the next five years owing to its growth to factors like rising incidence of anaphylaxis, growing prevalence of the targeted therapies, rising initiatives from regulatory bodies. Moreover, patients in a comparatively stable state prefer self-administration of the drug, with its advantages on usability, safe and less time taking. The market observes an increasing number of regulatory approvals resulting in enhancing the feasibility of the device for the patients, and this factor is also boosting the market growth.

Autoinjectors are medical devices that are used to self-administer drugs, such as insulin, epinephrine, and other injectable medications. They are designed to be easy to use, even for people with limited medical knowledge, and provide a convenient and effective way to deliver medication. One of the key factors driving the growth of the autoinjectors market is the increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis. As the number of people suffering from these conditions continues to rise, so too does the demand for efficient and effective drug delivery methods. Autoinjectors are seen as a key solution in this area, offering patients an easy and convenient way to self-administer medication. In addition to these factors, the autoinjectors market is also being driven by technological advancements in the healthcare sector. New innovations are constantly being developed, such as autoinjectors that can be connected to mobile devices and can provide real-time data on drug usage and patient compliance. This is making it easier than ever for patients to manage their conditions and ensuring that they receive the right dose of medication at the right time.

Government support toward the favorable reimbursements and technological advancements of the device like dosage monitoring are growth-favoring factors. New players may invest in the research and development of enhanced and better versions of the devices, thereby increasing the market shares. The market also fears a minor challenge of alternate routes of drug delivery like oral administrations or nasal sprays. They pose a threat to the growth of the market, which can be overcome by technological advancements. The process of developing single design autoinjectors for multiple drugs and biologics with variable viscosities suppresses the growth of the market

Rising Incidence of chronic diseases like Anaphylaxis

One of the primary factors driving the growth of the autoinjectors market is the rising incidence of chronic diseases. As the population continues to age and lifestyles become increasingly sedentary, the prevalence of conditions such as diabetes, multiple sclerosis, and rheumatoid arthritis has been on the rise. Autoinjectors provide a simple and convenient way for patients to self-administer medications, making them an ideal solution for managing these types of chronic conditions. Anaphylaxis is a life-threatening infectious disease that takes place as an allergic reaction of food, drugs, latex, and Hymenoptera stings. The cases of anaphylaxis are rising rapidly and thereby assures the largest market of the sub-segment in the future five years. Patients have registered infection and allergic reactions to even general anesthesia, making it almost impossible scenarios for a general surgical procedure. US, UK, and Australia have registered maximum cases of anaphylaxis. For instance, according to Wiley Online Library, in 2019, the incidence of anaphylaxis in children globally, ranging from 1 to 761 per 100 000 person-years for total anaphylaxis and 1 to 77 per 100 000 person-years for food-induced anaphylaxis. According to World Allergy Organization, the estimated number of deaths occurring each year due to anaphylaxis, this ranged from 5 or less in Hungary, 44 in Japan, to 500 in both China and the United States of America. Anaphylaxis, and deaths from anaphylaxis, are reported to be more frequent in adults than in children. anaphylaxis, and deaths from anaphylaxis, are reported to be more frequent in adults than in children which is expected to drive the growth of the global autoinjectors market.

Growing Technological Advancements

The rate of extensive research and technology development is growing for the growth of global autoinjectors market. The majority of market player are focused in developing technological solutions for autoinjectors to meet the demand for a viscous biologics delivery mechanism. For instance, in February 2021, As per the logics of thinner wall cannula technology, a US-based medical device firm namely Becton Dickinson (BD), have launch Intevia 2.25 mL. The patient-centered Intevia 2.25 mL has an 8-millimeter needle with a thinner wall and is compatible with BD Neopak XtraFlow prefill-able syringes. The other competitive market players are gaining interest in the formation of mergers, acquisitions, and partnerships for propelling the market growth. For instance, in March 2020, SHL medical, a Switzerland-based provider of advanced delivery devices, such as autoinjectors, pen injectors, advanced inhalers, and wearable drug delivery systems, acquired Weibel CDS. Weibal CDS is a medical technology company of Swiss specialized in doing research and development of injection systems and devices. Profit behind this acquisition SHL is expected to expand its portfolio of innovative drug delivery solutions for injection devices which is expected to drive the growth of global autoinjectors market.

In addition, the technological advancements in the healthcare industry have also played a significant role in the growth of the autoinjectors market. The development of advanced sensors, smart devices, and the internet of things (IoT) has allowed for the integration of autoinjectors with mobile applications and remote monitoring systems. This integration provides real-time monitoring of medication use, making it easier for healthcare providers to monitor patient compliance and adjust treatment plans as necessary. Furthermore, the demand for self-administration of drugs is also contributing to the growth of the autoinjectors market. Patients are increasingly taking control of their healthcare, and many are looking for ways to manage their conditions independently. Autoinjectors provide an easy-to-use and convenient solution for self-administering medication, allowing patients to manage their conditions more effectively.

Lastly, the increasing availability of generic versions of autoinjectors has made these devices more affordable and accessible to a wider range of patients. This has led to increased adoption of autoinjectors, especially in emerging markets where healthcare costs can be a significant burden.

Complexity in Developing Auto-injectors for Multiple Drugs

The different type of drugs has different viscosities, drugs with different viscosity require springs with different physical characteristics such as composition, length and thickness to create spring rate that provides enough power to push higher viscosity drugs and biologics through the syringe to the needle. In the present scenario, most of the market players are trying to develop the device with required characteristics. The companies are focusing on extensive research and developments activities to stay competitive which is considered as a big factor of suppressing the growth of global autoinjectors market.


Download Free Sample Report

Market Segmentation

The global autoinjector market is segmented by therapy, design, product, technology, type, route of administration, end-user, regional distribution, and competitional landscape. Based on therapy, the market is further segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others. Based on design, the market is further segmented into standardized, customized. Based on product, the market is further segmented into prefilled, fillable. Based on technology, the market is further segmented into automated, manual. Based on type, the market is further segmented into disposable, reusable. Based on route of administration, the market is further segmented into intravenous, subcutaneous. Based on end user, the market is further segmented into hospitals & clinics, ambulatory care settings, home care settings.

Company Profiles

Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, Medeca Pharma AB, etc., are some of the key players operating in the global atherectomy devices market.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2022

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Therapy

·         Design

·         Product

·         Technology

·         Type

·         Route of Administration

·         End User

·         Region

·         Company

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; UAE; Saudi Arabia; South Africa; Kuwait

Key Companies Profiled

Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, Medeca Pharma AB.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global autoinjectors market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Autoinjectors Market, By Therapy:
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Diabetes
    • Anaphylaxis
    • Others
  • Global Autoinjectors Market, By Design:
    • Standardized
    • Customized
  • Global Autoinjectors Market, By Product:
    • Prefilled
    • Fillable
  • Global Autoinjectors Market, By Technology:
    • Automated
    • Manual
  • Global Autoinjectors Market, By Type:
    • Disposable
    • Reusable
  • Global Autoinjectors Market, By Route of Administrations:
    • Intravenous
    • Subcutaneous
  • Global Autoinjectors Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Care Settings
    • Home Care Settings
  • Global Autoinjectors Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global autoinjectors market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Autoinjectors Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Autoinjectors Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others)

5.2.2.     By Design (Standardized v/s Customized)

5.2.3.     By Product (Prefilled v/s Fillable)

5.2.4.     By Technology (Automated v/s Manual)

5.2.5.     By Type (Disposable v/s Reusable)

5.2.6.     By Route of Administration (Intravenous v/s Subcutaneous)

5.2.7.     By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings)

5.2.8.     By Company (2022)

5.2.9.     By Region

5.3.  Product Market Map

6.    North America Autoinjectors Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Therapy

6.2.2.     By Design

6.2.3.     By Product

6.2.4.     By Technology

6.2.5.     By Type

6.2.6.     By Route of Administration

6.2.7.     By End User

6.2.8.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Autoinjectors Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Therapy

6.3.1.2.2.             By Design

6.3.1.2.3.             By Product

6.3.1.2.4.             By Technology

6.3.1.2.5.             By Type

6.3.1.2.6.             By Route of Administration

6.3.1.2.7.             By End User

6.3.2.     Mexico Autoinjectors Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Therapy

6.3.2.2.2.             By Design

6.3.2.2.3.             By Product

6.3.2.2.4.             By Technology

6.3.2.2.5.             By Type

6.3.2.2.6.             By Route of Administration

6.3.2.2.7.             By End User

6.3.3.     Canada Autoinjectors Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Therapy

6.3.3.2.2.             By Design

6.3.3.2.3.             By Product

6.3.3.2.4.             By Technology

6.3.3.2.5.             By Type

6.3.3.2.6.             By Route of Administration

6.3.3.2.7.             By End User

7.    Europe Autoinjectors Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Therapy

7.2.2.     By Design

7.2.3.     By Product

7.2.4.     By Technology

7.2.5.     By Type

7.2.6.     By Route of Administration

7.2.7.     By End User

7.2.8.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Autoinjectors Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapy

7.3.1.2.2.             By Design

7.3.1.2.3.             By Product

7.3.1.2.4.             By Technology

7.3.1.2.5.             By Type

7.3.1.2.6.             By Route of Administration

7.3.1.2.7.             By End User

7.3.2.     Germany Autoinjectors Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapy

7.3.2.2.2.             By Design

7.3.2.2.3.             By Product

7.3.2.2.4.             By Technology

7.3.2.2.5.             By Type

7.3.2.2.6.             By Route of Administration

7.3.2.2.7.             By End User

7.3.3.     United Kingdom Autoinjectors Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapy

7.3.3.2.2.             By Design

7.3.3.2.3.             By Product

7.3.3.2.4.             By Technology

7.3.3.2.5.             By Type

7.3.3.2.6.             By Route of Administration

7.3.3.2.7.             By End User

7.3.4.     Italy Autoinjectors Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Therapy

7.3.4.2.2.             By Design

7.3.4.2.3.             By Product

7.3.4.2.4.             By Technology

7.3.4.2.5.             By Type

7.3.4.2.6.             By Route of Administration

7.3.4.2.7.             By End User

7.3.5.     Spain Autoinjectors Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Therapy

7.3.5.2.2.             By Design

7.3.5.2.3.             By Product

7.3.5.2.4.             By Technology

7.3.5.2.5.             By Type

7.3.5.2.6.             By Route of Administration

7.3.5.2.7.             By End User

8.    Asia-Pacific Autoinjectors Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By Design

8.2.3.     By Product

8.2.4.     By Technology

8.2.5.     By Type

8.2.6.     By Route of Administration

8.2.7.     By End User

8.2.8.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Autoinjectors Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapy

8.3.1.2.2.             By Design

8.3.1.2.3.             By Product

8.3.1.2.4.             By Technology

8.3.1.2.5.             By Type

8.3.1.2.6.             By Route of Administration

8.3.1.2.7.             By End User

8.3.2.     India Autoinjectors Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapy

8.3.2.2.2.             By Design

8.3.2.2.3.             By Product

8.3.2.2.4.             By Technology

8.3.2.2.5.             By Type

8.3.2.2.6.             By Route of Administration

8.3.2.2.7.             By End User

8.3.3.     South Korea Autoinjectors Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapy

8.3.3.2.2.             By Design

8.3.3.2.3.             By Product